We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lectin-Based Test Estimates Glycated Hemoglobin

By LabMedica International staff writers
Posted on 29 Feb 2012
A novel method has been developed for estimating the glycated hemoglobin (HbA1c) in normal and diabetic patients using a glucose specific lectin.

The quantitative precipitin method was performed for the interaction between the glucose-specific lectin Concanavalin A (Con A) and the glucose-containing RBC-lysate for the estimation of calculated HbA1c% from a standard curve.

Scientists at the Cancer Centre Welfare Home and Research Institute, (Kolkata, West Bengal, India) selected 16 patients of both sexes with type-2 diabetes, age range 35–60 years, and four patients with newly diagnosed type-1 diabetes, age range 15–41 years . Twenty sex-matched normal healthy subjects, age range 33-65 years, were also included as controls. A precipitation test of red cell lysate and Con-A was performed and the precipitate estimated spectrophotometrically at 480 nm. For reference, plasma glucose was estimated from the diabetic and nondiabetic subjects by glucose oxidase method using phenol 4-aminophenazone and HbA1c% were measured by ion-exchange high performance liquid chromatography (HPLC) method with the Bio-Rad D-10 analyzer (BioRad; Hercules, CA, USA).

The absorbance range of the precipitate was 0.14–0.20 in normal subjects and the corresponding calculated HbA1c% along with plasma glucose levels was 4.1%-5.8% and 82-101 mg/dL, respectively. For the diabetic patients, HbA1c results were between 6.3%-12.2%, and the plasma glucose range was 120-292 mg/dL. Similar results were observed for HbA1c% (6.1%-11.9%) of the same diabetic samples measured by conventional ion-exchange HPLC. The nondiabetic and diabetic hemoglobin variant subjects consisted of HbE-β-thalassemia, β-thalassemia carrier state, HbE trait, and HbS trait, showed similar HbA1c% by the lectin-based assay when compared with standard HPLC method.

The authors concluded that the lectin-based assay may be adopted to estimate glycated hemoglobin level in differentiating between normal and diabetic patients. This assay offers a good correlation with standard HPLC method, and moreover, the method is convenient, cheap, and needs no sophisticated instruments, and therefore suitable for laboratories in poor resource settings. The study was published online on January 24, 2012, in the Journal of Clinical Laboratory Analysis.

Related Links:

Cancer Centre Welfare Home and Research Institute
BioRad




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
29 Feb 2012  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
29 Feb 2012  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
29 Feb 2012  |   Clinical Chem.